EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays

Tumor-associated autoantibodies (AAbs) have been described in patients with lung cancer, and the EarlyCDT®-Lung test that measures such AAbs is available as an aid for the early detection of lung cancer in high-risk populations. Improvements in specificity would improve its cost-effectiveness, as we...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Caroline J., Healey, Graham F., Murray, Andrea, Boyle, Peter, Robertson, Chris, Peek, Laura J., Allen, Jared, Thorpe, Alison J., Hamilton-Fairley, Geoffrey, Parsy-Kowalska, Celine B., MacDonald, Isabel K., Jewell, William, Maddison, Paul, Robertson, John F. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460172/
https://www.ncbi.nlm.nih.gov/pubmed/22492236
http://dx.doi.org/10.1007/s13277-012-0379-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460172/
https://www.ncbi.nlm.nih.gov/pubmed/22492236
http://dx.doi.org/10.1007/s13277-012-0379-2

Ejemplares similares